Sydney Lupkin
๐ค SpeakerAppearances Over Time
Podcast Appearances
So this weekend marked a very important anniversary.
Not our friendiversary, Emily.
the anniversary of a pill that revolutionized cancer care.
Oh, that's way better.
Not that I don't love you.
So the drug is called Gleevec, and May 10th marks 25 years since the Food and Drug Administration first approved it.
So Gleevec, why is this pill such a big deal?
Well, it's considered one of the first targeted cancer therapies.
And what it really did was make some cancers that were once fatal not so fatal anymore.
Wow, that is a big deal.
And I talked about it with this guy in Atlanta.
His name is Mel Mann.
And he told me that in 1995, he was dealing with some back pain and fatigue, but it wasn't really clear why.